RB's Health sales hit by Scholl and cyberattack

25 July 2017 - Deborah Wilkes

Archived

Sales at RB's Health division were down by 4% on a like-for-like basis in the second quarter of 2017. The company said declines for Scholl/Amopé footcare products had continued to have an impact, and "cyberattack issues" at the very end of the quarter had contributed to the fall.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: